MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
Cipponi, Arcadi, Goode, David L., Bedo, Justin, McCabe, Mark J., Pajic, Marina, Croucher, David R., Rajal, Alvaro Gonzalez, Junankar, Simon R., Saunders, Darren N., Lobachevsky, Pavel, Papenfuss, Anthony T., Nessem, Danielle, Nobis, Max, Warren, Sean C., Timpson, Paul, Cowley, Mark, Vargas, Ana C., Qiu, Min R., Generali, Daniele G., Keerthikumar, Shivakumar, Nguyen, Uyen, Corcoran, Niall M., Long, Georgina V., Blay, Jean-Yves, Thomas, David M.
Published in Science (American Association for the Advancement of Science) (05.06.2020)
Published in Science (American Association for the Advancement of Science) (05.06.2020)
Get full text
Journal Article
Integration of silk protein in organic and light-emitting transistors
Capelli, R., Amsden, J.J., Generali, G., Toffanin, S., Benfenati, V., Muccini, M., Kaplan, D.L., Omenetto, F.G., Zamboni, R.
Published in Organic electronics (01.07.2011)
Published in Organic electronics (01.07.2011)
Get full text
Journal Article
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer
Musolino, A, Naldi, N, Dieci, M V, Zanoni, D, Rimanti, A, Boggiani, D, Sgargi, P, Generali, D G, Piacentini, F, Ambroggi, M, Cagossi, K, Gianni, L, Sarti, S, Bisagni, G, Ardizzoni, A, Conte, P F, Guarneri, V
Published in The pharmacogenomics journal (01.10.2016)
Published in The pharmacogenomics journal (01.10.2016)
Get full text
Journal Article
Anthracene-based molecular emitters for non-doped deep-blue organic light emitting transistors
Zambianchi, M., Benvenuti, E., Bettini, C., Zanardi, C., Seeber, R., Gentili, D., Cavallini, M., Muccini, M., Biondo, V., Soldano, C., Generali, G., Toffanin, S., Melucci, M.
Published in Journal of materials chemistry. C, Materials for optical and electronic devices (01.01.2016)
Published in Journal of materials chemistry. C, Materials for optical and electronic devices (01.01.2016)
Get full text
Journal Article
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
Dieci, M.V., Prat, A., Tagliafico, E., Paré, L., Ficarra, G., Bisagni, G., Piacentini, F., Generali, D.G., Conte, P., Guarneri, V.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial
Guarneri, Valentina, Dieci, Maria V., Griguolo, Gaia, Miglietta, Federica, Girardi, Fabio, Bisagni, Giancarlo, Generali, Daniele G., Cagossi, Katia, Sarti, Samanta, Frassoldati, Antonio, Gianni, Lorenzo, Cavanna, Luigi, Pinotti, Graziella, Musolino, Antonino, Piacentini, Federico, Cinieri, Saverio, Prat, Aleix, Conte, PierFranco
Published in European journal of cancer (1990) (01.08.2021)
Published in European journal of cancer (1990) (01.08.2021)
Get full text
Journal Article
Breast tumour angiogenesis
Fox, Stephen B, Generali, Daniele G, Harris, Adrian L
Published in Breast cancer research : BCR (01.01.2007)
Published in Breast cancer research : BCR (01.01.2007)
Get full text
Journal Article
Analysis of ESD effects on organic thin-film-transistors by means of TLP technique
Wrachien, N., Barbato, M., Cester, A., Rizzo, A., Meneghesso, G., D'Alpaos, R., Turatti, G., Generali, G., Muccini, M.
Published in 2016 IEEE International Reliability Physics Symposium (IRPS) (01.04.2016)
Published in 2016 IEEE International Reliability Physics Symposium (IRPS) (01.04.2016)
Get full text
Conference Proceeding
Anthracene-based molecular emitters for non-doped deep-blue organic light emitting transistorsElectronic supplementary information (ESI) available: Differential scanning calorimetry, optical properties of BDNA and BD3 materials in solution and thin films, morphology of BDNA, BD3 and DiPAXA, and OLET performance of BDNA and BD3. See DOI: 10.1039/c6tc02949c
Zambianchi, M, Benvenuti, E, Bettini, C, Zanardi, C, Seeber, R, Gentili, D, Cavallini, M, Muccini, M, Biondo, V, Soldano, C, Generali, G, Toffanin, S, Melucci, M
Year of Publication 13.10.2016
Year of Publication 13.10.2016
Get full text
Journal Article
244PImmune infiltrate composition across intrinsic subtypes in hormone receptor (HR)+/HER2- early breast cancer (BC) enrolled in the prospective LETLOB trial
Griguolo, G, Dieci, M V, Paré, L, Miglietta, F, Generali, D G, Frassoldati, A, Bisagni, G, Piacentini, F, Tagliafico, E, Cagossi, K, Ficarra, G, Prat, A, Conte, P F, Guarneri, V
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Photoswitchable OFETs controlled by optical bistability in the dielectric layer
Sworakowski, J., Lutsyk, P., Janus, K., Generali, G., Capelli, R., Muccini, M., Kochalska, A., Nespurek, S.
Published in 2011 - 14th International Symposium on Electrets (01.08.2011)
Published in 2011 - 14th International Symposium on Electrets (01.08.2011)
Get full text
Conference Proceeding
Abstract P6-08-01: A cost-consequence analysis of pertuzumab in the neoadjuvant treatment of high-risk HER2+ Early-Stage Breast Cancer (EBC): health-economic considerations for drug availability in Italy
Zambelli, Alberto, Cazzaniga, Marina Elena, La Verde, Nicla, Munzone, Elisabetta, Antonazzo, Ippazio Cosimo, Mantovani, Lorenzo Giovanni, Mancuso, Anna, Generali, Daniele G., Cortesi, Paolo Angelo
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract P4-02-13: Homologous recombination deficiency, RB-loss gene signatures, intrinsic subtype and response to neoadjuvant treatment in HR+/HER2- early breast cancer: a correlative analysis of two phase II trials
Griguolo, Gaia, Miglietta, Federica, Paré, Laia, Generali, Daniele G., Frassoldati, Antonio, Musolino, Antonino, Spazzapan, Simon, Vernaci, Grazia, Giarratano, Tommaso, Mele, Marcello Lo, Bisagni, Giancarlo, Piacentini, Federico, Tagliafico, Enrico, Cagossi, Katia, Schiavi, Francesca, Pinato, Claudia, Prat, Aleix, Guarneri, Valentina, Dieci, Maria Vittoria
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract P3-06-23: Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in patients with HER2-positive operable breast cancer
Musolino, Antonino, Guarneri, Valentina, Naldi, Nadia, Bortesi, Beatrice, Boggiani, Daniela, Sgargi, Paolo, Generali, Daniele G, Piacentini, Federico, Dieci, Maria V, Ambroggi, Massimo, Cagossi, Katia, Gianni, Lorenzo, Sarti, Samanta, Bisagni, Giancarlo, Frassoldati, Antonio, Conte, Pierfranco, Ardizzoni, Andrea
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer
Conte, P. F., Guarneri, V., Generali, D. G., Bottini, A., Bazzola, L., Piacentini, F., Artioli, F., Cagossi, K., Bisagni, G., Bagnalasta, M., Tagliafico, E., Barbieri, E., Cavanna, L., Ravaioli, A., D'Amico, R., Vicini, R., Frassoldati, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
First-line bevacizumab (B) plus paclitaxel (P) in HER2-negative (HER2-ve) metastatic breast cancer (mBC): Efficacy and safety in an Italian multicenter retrospective study
Andreis, D., Scandurra, G., Santini, D., Gucciardino, C., La Verde, N. M., Girelli, S., Alabiso, I., Saetta, A., Atzori, F., Collovà, E., Ferzi, A., Gori, S., Lipari, H., Saggia, C., Marcon, I., Generali, D. G.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial)
Guarneri, V., Frassoldati, A., Bottini, A., Generali, D. G., Cagossi, K., Artioli, F., Bisagni, G., Boni, C., Ravaioli, A., Amadori, D., Musolino, A., Cavanna, L., Untch, M., Orlando, L., Giardina, G., Piacentini, F., Tagliafico, E., Bagnalasta, M., D'Amico, R., Conte, P. F.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Abstract P2-08-03: Survival analysis of the prospective randomized Cher-Lob study: Correlation with tumor infiltrating lymphocytes
Dieci, MV, Bisagni, G, Cagossi, K, Generali, DG, Sarti, S, Piacentini, F, Conte, P, Guarneri, V
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Retrospective analysis of patients with male breast cancer: Report from O.R.I.O.N. collaborative group
Generali, D. G., Garassino, M. C., Lonardi, S., Bettini, A., Rossello, R., Martelli, O., Collova, E., Rampinelli, I., Mancuso, A., Saggia, C., Torri, V.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Down-regulation of HIF-1α expression by letrozole in ER+ ve breast cancer patients
Generali, D. G., Berruti, A., Fox, S. B., Brizzi, M., Bonardi, S., Milani, M., Bersiga, A., Dionisio, R., Dogliotti, L., Bottini, A., Harris, A. L.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article